Herbito, Maricel .

HRN: 20-60-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
CEFUROXIME 1.5GM (VIAL)
05/13/2024
05/13/2024
IV
1.5g
ON Call OR
CS
Waiting Final Action 
05/13/2024
CEFUROXIME 1.5GM (VIAL)
05/13/2024
05/14/2024
IV
1.5
Q8
CS
Waiting Final Action 
05/13/2024
CEFOTAXIME 500MG (VIAL)
05/13/2024
05/19/2024
PO
500mg
BID
Cs
Waiting Final Action 
05/13/2024
METRONIDAZOLE 500MG (TAB)
05/13/2024
05/19/2024
PO
500mg
BID
Cs
Waiting Final Action 
05/13/2024
CEFUROXIME 500MG (TAB)
05/13/2024
05/19/2024
PO
500mg
BId
Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: